• Most Popular
  • Most Shared

Genmab starts study for colorectal cancer drug

Fri May 30, 2008 2:49am EDT

Stocks

   

COPENHAGEN, May 30 (Reuters) - Danish biotech firm Genmab (GEN.CO) said on Monday it has started a Phase I/II study with its HuMax-EGFr experimental drug for the treatment of colorectal cancer.

The drug, also known as zalutumumab, will be studied in combination with irinotecan chemotherapy on up to 97 patients who have failed standard chemotherapy.

The company did not say when it expected to complete the study. (Reporting by Gelu Sulugiuc; Editing by Greg Mahlich)



More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets